Suppr超能文献

基于粪便免疫化学试验的筛查方案中,阴性结肠镜检查后的结肠镜检查间期结直肠癌。

Interval post-colonoscopy colorectal cancer following a negative colonoscopy in a fecal immunochemical test-based screening program.

机构信息

Department of Public Health, Erasmus MC University Medical Center, Rotterdam, The Netherlands.

Department of Gastroenterology and Hepatology, Erasmus MC University Medical Center, Rotterdam, The Netherlands.

出版信息

Endoscopy. 2023 Dec;55(12):1061-1069. doi: 10.1055/a-2136-6564. Epub 2023 Oct 4.

Abstract

BACKGROUND

In the Dutch colorectal (CRC) screening program, fecal immunochemical test (FIT)-positive individuals are referred for colonoscopy. If no relevant findings are detected at colonoscopy, individuals are reinvited for FIT screening after 10 years. We aimed to assess CRC risk after a negative colonoscopy in FIT-positive individuals.

METHODS

In this cross-sectional cohort study, data were extracted from the Dutch national screening information system. Participants with a positive FIT followed by a negative colonoscopy between 2014 and 2018 were included. A negative colonoscopy was defined as a colonoscopy during which no more than one nonvillous, nonproximal adenoma < 10 mm or serrated polyp < 10 mm was found. The main outcome was interval post-colonoscopy CRC (iPCCRC) risk. iPCCRC risk was reviewed against the risk of interval CRC after a negative FIT (FIT IC) with a 2-year screening interval.

RESULTS

35 052 FIT-positive participants had a negative colonoscopy and 24 iPCCRCs were diagnosed, resulting in an iPCCRC risk of 6.85 (95 %CI 4.60-10.19) per 10 000 individuals after a median follow-up of 1.4 years. After 2.5 years of follow-up, age-adjusted iPCCRC risk was approximately equal to FIT IC risk at 2 years.

CONCLUSION

Risk of iPCCRC within a FIT-based CRC screening program was low during the first years after colonos-copy but, after 2.5 years, was the same as the risk in FIT-negative individuals at 2 years, when they are reinvited for screening. Colonoscopy quality may therefore require further improvement and FIT screening interval may need to be reduced after negative colonoscopy.

摘要

背景

在荷兰结直肠癌(CRC)筛查计划中,粪便免疫化学测试(FIT)阳性者将被转介进行结肠镜检查。如果结肠镜检查未发现相关发现,将在 10 年后再次邀请这些人进行 FIT 筛查。我们旨在评估 FIT 阳性者结肠镜检查阴性后的 CRC 风险。

方法

在这项横断面队列研究中,数据从荷兰国家筛查信息系统中提取。纳入 2014 年至 2018 年间进行阳性 FIT 检查后阴性结肠镜检查的参与者。阴性结肠镜检查定义为结肠镜检查期间仅发现不超过一个非绒毛、非近端腺瘤<10mm 或锯齿状息肉<10mm。主要结局是结肠镜检查后间隔期 CRC(iPCCRC)风险。使用 2 年筛查间隔的阴性 FIT(FIT IC)后的间隔 CRC 风险来审查 iPCCRC 风险。

结果

35052 名 FIT 阳性者进行了阴性结肠镜检查,诊断出 24 例 iPCCRC,在中位随访 1.4 年后,每 10000 人中发生 iPCCRC 的风险为 6.85(95%CI 4.60-10.19)。随访 2.5 年后,年龄调整后的 iPCCRC 风险与 2 年时的 FIT IC 风险大致相同。

结论

在基于 FIT 的 CRC 筛查计划中,结肠镜检查后最初几年内 iPCCRC 的风险较低,但 2.5 年后,与 2 年时再次邀请进行筛查的 FIT 阴性者的风险相同。因此,结肠镜检查质量可能需要进一步提高,并且在阴性结肠镜检查后 FIT 筛查间隔可能需要缩短。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6e4b/10684335/307d147a2d91/10-1055-a-2136-6564-i22404en1.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验